Meta-analysis in adolescents and young adults with ALL: paediatric (asparaginase-based) regimens were associated with higher 5-year OS (RR 1.40); HSCT in first remission was associated with lower 5-year OS (RR 0.72). Certainty was low.
Meta-analysis
Sereda et al. Pediatric-inspired regimens and HSCT for adolescents and young adults with acute lymphoblastic leukemia